Authors
Loading...
Randomized trial evaluates tamoxifen-loaded lipid nanoparticles to enhance therapeutic efficacy in triple-negative breast cancer, indicating a novel treatment strategy.
Gunbay et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: